Keyphrases
β2-Adrenergic Receptor (β2AR)
100%
Adrenergic Receptors
100%
Myopic Choroidal Neovascularization (mCNV)
100%
Vascular Endothelial Growth Factor
88%
Interleukin-6 Expression
44%
Receptor Antagonism
44%
Neovascular Age-related Macular Degeneration (nAMD)
44%
Retinal pigment Epithelium
33%
Interleukin-6 Levels
22%
Agonism
22%
Interleukin-6
22%
Anti-vascular Endothelial Growth Factor Therapy
22%
Adrenergic Receptor Signaling
11%
Laser Therapy
11%
Serum interleukin-6
11%
Adrenergic Receptor Blocker
11%
IL-6 Blockade
11%
Choroidal Endothelial Cells
11%
Laser-induced Choroidal Neovascularization
11%
Inflammatory Pathways
11%
Retinal Neovascularization
11%
Ischemic Retinopathy
11%
Laser-induced
11%
Developing World
11%
Human Fetus
11%
Signaling Pathway
11%
Microglia
11%
Treatment Burden
11%
Inflammatory Cytokines
11%
Regress
11%
Physiological Function
11%
Inflammatory Cells
11%
Hemangioma
11%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
11%
Vascular Endothelial Growth Factor Expression
11%
Propranolol
11%
MRNA Expression
11%
Causes of Blindness
11%
Mouse Model
11%
Resident Macrophages
11%
Potential Alternatives
11%
Medicine and Dentistry
Vasculotropin
100%
Choroidal Neovascularization
100%
Beta 2 Adrenergic Receptor
100%
Adrenergic Receptor
83%
Interleukin 6
75%
Wet Macular Degeneration
33%
Blood Clotting Factor 6
25%
Visual Pigment
25%
Epithelial Cell
16%
Diseases
16%
Low Level Laser Therapy
8%
Laser-Induced Choroidal Neovascularization
8%
Retinopathy
8%
Adrenergic Receptor Blocking Agent
8%
Macrophage
8%
Hemangioma
8%
Retina Neovascularization
8%
Inflammatory Cell
8%
Inflammatory Cytokine
8%
Choroidal Endothelial Cell
8%
Signal Transduction
8%
Propranolol
8%
Microglia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Beta 2 Adrenergic Receptor
100%
Subretinal Neovascularization
100%
Vasculotropin
100%
Adrenergic Receptor
83%
Interleukin 6
75%
Wet Macular Degeneration
33%
Blood Clotting Factor 6
25%
Visual Pigment
25%
Disease
16%
Mouse
12%
Mouse Model
8%
Propranolol
8%
Adrenergic Receptor Blocking Agent
8%
Retina Neovascularization
8%
Laser-Induced Choroidal Neovascularization
8%
Cytokine
8%
Retinopathy
8%
Hemangioma
8%